A 3-year randomized therapeutic trial of nitisinone in alkaptonuria - Wikidata - awgldk - TriplyDB

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

http://www.wikidata.org/entity/Q24624747

about

Treatment of nongout joint deposition diseases: an update Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone First report of a deletion encompassing an entire exon in the homogentisate 1,2-dioxygenase gene causing alkaptonuria.Aortic stenosis and vascular calcifications in alkaptonuria Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report.The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical Analysis Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with Alkaptonuria Age-Related Deviation of Gait from Normality in Alkaptonuria.Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.Brown urine and black hip.Alkaptonuria: leading to the treasure in exceptions.Alkaptonuria is a novel human secondary amyloidogenic disease Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.Alkaptonuria.The role of nitisinone in tyrosine pathway disorders.Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.Progress toward improved therapies for inborn errors of metabolism.Acute fatal metabolic complications in alkaptonuria.A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.Osteoarticular cells tolerate short-term exposure to nitisinone-implications in alkaptonuria.The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.Alkaptonuria and Pompe disease in one patient: metabolic and molecular analysis.Osler's sign revisited.A simplified staging system based on the radiological findings in different stages of ochronotic spondyloarthropathy.Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury.Blackish Pigmentation of the Aorta in Patient with Alkaptonuria and Heyde's Syndrome.Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion.Liver Transplantation for Hereditary Tyrosinaemia Type 1 in the United Kingdom.Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.Alkaptonuric ochronosis: a clinical study from Ardabil, Iran.Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features.From Weed Killer to Wonder Drug.

P2860

Q26852957-10B5EC94-3EA2-4F49-892E-0E47BE92E006 Q28249590-72FC7ECD-F45A-4BD0-96C8-EE93B0F6FFDE Q28287543-48994E39-4404-4093-9FC7-0248B22763C5 Q30366939-1480311D-CF7A-4A12-A82E-CBB8F0399948 Q30504971-D9C5298B-0001-4141-9139-B6B62A14A24E Q33993821-91677BE7-06CE-41FC-9232-2CB5F1605EC3 Q34560227-76B69011-BD3B-4E32-B5EF-5EFDEDD241E1 Q36090565-52A6FA32-58A4-45F0-933A-1AEF431530AC Q36090570-CBD5D413-A6A5-4A90-A7FE-BE4E9CC51F5D Q36090577-387C3158-EE7C-4044-B8A8-7B98A49CBA2F Q36090586-80D4DBE1-D840-4BDB-BBF7-A89CDE63D761 Q36090590-14CD5BBE-83ED-4A08-A039-3228AACA0824 Q36315143-454DFD24-8F7B-48A8-96DF-35CFCD458953 Q36433474-71618CE2-4A7F-4CAB-904B-D8BE4380B8F1 Q37209177-84754BD4-D9E8-4F5A-9DB4-2A7E8E204C29 Q38160929-A8ECD6B0-7FCB-4A7A-BA9F-566F95065518 Q38227178-FB6B2FFE-7FF1-48E5-9501-94D5A4DCF8F5 Q38255379-29420B4E-7C31-4707-8907-319A8416699E Q38414587-DDA00216-B300-4297-BD9D-39922B262E2A Q38601073-A5C96C1A-B111-4924-A3EA-22798A68BBB0 Q38644004-A10FDB07-2E30-42D3-86F6-B66E44965F6F Q38827337-B995923D-09FF-48F5-A778-CF3A4815E615 Q38869592-E8D2C233-8FB6-4851-93E1-F9E4139D0AFF Q39024172-2D84270C-CBC0-40EC-9C1F-A1ACD3A4C311 Q39061550-7E85246C-C4D6-4A5E-9B8A-4DF094AF7A0C Q39147959-D89992B6-8014-468A-976E-C8C530F4B220 Q39944647-ED62C15A-078D-4FA4-A3A6-BC9A39569766 Q40413861-F57F1685-1A9D-43D8-90E8-6B8808F7159F Q42383123-5FBEFE7B-0549-4090-A518-9E1809F9E31A Q42545345-DC8F3D6F-E8B4-4687-B350-3C502B8A0342 Q43123162-E78F254E-9DAB-44A2-970D-4FA46384DF40 Q43124913-EE7981E1-77F8-4606-920D-9F271D450F89 Q47753281-E9897500-EE9C-4049-9535-030517A3CC3B Q47844194-1A9B65DF-1189-43CA-B6F4-65FF84EE5577 Q48583044-3E7AF16A-D54E-41B2-8593-8CD828AEF644 Q49935371-534C252B-2B55-4A56-AB64-BC24EB31FAC5 Q50226081-E737CCA1-0353-4CBF-B29E-1D3C048AA453 Q50850348-E3C0FBD0-440D-40A0-A80B-3AA7D142C4BC Q52588914-96EE5E00-DC5C-4510-B5C2-93F617B91124 Q53136159-A5AF1A19-8471-4410-9241-F210816DDF64

P2860

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

http://www.wikidata.org/entity/Q24624747

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@ast

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@en

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@nl

type

label

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@ast

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@en

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@nl

prefLabel

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@ast

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@en

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@nl

P1433

Q24624747-2465E155-1686-4305-8178-5205AE2DF900

P1476

Q24624747-AF76622E-B696-4D47-AB1E-D4F358023E75

P2093

Q24624747-0AB6F638-DE6E-42D9-855F-089157E84BE4

Q24624747-0D69C7A1-2BF8-4D7F-AF92-B943F5AFF129

Q24624747-3435DA7C-ED71-4F29-80B3-C8834874E9DD

Q24624747-38B96EC5-F24A-4EF0-A82C-D173230F0D8C

Q24624747-4D3F9CBB-EF3D-4391-890F-C1D56B94B14C

Q24624747-5CB673E1-512B-4C7C-80AD-AC8E542D3F76

Q24624747-6AB996E8-3848-4D4C-973D-C6E032E13601

Q24624747-717BD692-2D9C-4372-8DAD-8C6D1B23F84E

Q24624747-9457BC01-263F-481E-8375-1E753283D605

Q24624747-A9D7C0D4-0047-470C-B355-225CC1486F04

P2860

Q24624747-0C524910-F54E-4F82-A277-9D48113F8E2F

Q24624747-1BF6C016-35EC-4D61-9908-CB3C6674FCC8

Q24624747-39427450-8FD4-47F1-A4F1-7B81E8BBD29B

Q24624747-3C131B5E-887C-469B-B29F-8AFE8690EEBC

Q24624747-46E59131-3515-4185-8E70-A9BD7C7911F6

Q24624747-498517C3-E02A-4B6C-8C88-A430382BC9E8

Q24624747-4E6C986C-953D-4316-AF41-E86A0B6965D8

Q24624747-55188906-B3F4-46B4-BCFF-C0BA584C07B2

Q24624747-6846B163-8E10-481F-B5F9-47775B90021C

Q24624747-6DF75544-DF92-483A-BE84-26FB1CEF36BA

P304

Q24624747-B75B9B29-0BB4-43A3-BC23-46A0B8A35375

P31

Q24624747-0CAC882A-D3AC-4D0A-96E9-1F1260DCC1F6

P356

Q24624747-FD1EA66A-9D58-4160-9145-4A574F8FFF6E

P407

Q24624747-1F7F27F4-09A4-46AE-A298-8CE389C3A0CB

P433

Q24624747-8F044416-FA57-4CB5-8D23-3EAA00F136F4

P478

Q24624747-9608FA16-829C-41FA-938C-8693F48FB50A

P577

Q24624747-CA34AC1D-7BE2-44B4-9E6E-583EF4908270

P5875

Q24624747-6A4557DF-980D-4BD2-A321-1D7D11C80F0F

P698

Q24624747-8CC38BC3-257E-4317-822C-3132AF8FB3CE

P921

Q24624747-62E0D461-42FA-4DA6-926A-2548097A5FFD

P932

Q24624747-60B4099B-AD53-4D39-B61A-AFCDB3831A04

P356

J.YMGME.2011.04.016

P1433

Molecular Genetics and Metabolism

P1476

A 3-year randomized therapeutic trial of nitisinone in alkaptonuria

@en

P2093

Ekaterini Tsilou

http://www.w3.org/2001/XMLSchema#string

Elizabeth Moylan

http://www.w3.org/2001/XMLSchema#string

Isa Bernardini

http://www.w3.org/2001/XMLSchema#string

James C Reynolds

http://www.w3.org/2001/XMLSchema#string

James Troendle

http://www.w3.org/2001/XMLSchema#string

Joy Bryant

http://www.w3.org/2001/XMLSchema#string

Kevin E O'Brien

http://www.w3.org/2001/XMLSchema#string

Michael A Kayser

http://www.w3.org/2001/XMLSchema#string

Monique B Perry

http://www.w3.org/2001/XMLSchema#string

Pim Suwannarat

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of alkaptonuria

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

Normal range of spinal mobility. An objective clinical study.

Measurement of back movement.

The nature of the defect in tyrosine metabolism in alcaptonuria.

Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC.

Use of nitisinone in patients with alkaptonuria.

The genetic tyrosinemias.

Reference equations for the six-minute walk in healthy adults.

NTBC and alkaptonuria.

P304

307-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2011.04.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51172934

http://www.w3.org/2001/XMLSchema#string

P698

21620748

http://www.w3.org/2001/XMLSchema#string

P921

P932

3148330

http://www.w3.org/2001/XMLSchema#string